1.Clinical Observation of Electroacupuncture at Baihuanshu (BL30) and Huiyang (BL55) for Chronic Prostatitis
Mingyue YANG ; Jian YING ; Junxian LI ; Siyou WANG ; Minjie ZHOU ; Wei ZHANG
Shanghai Journal of Acupuncture and Moxibustion 2014;(10):913-915
Objective To observe the therapeutic efficacy of electroacupuncture at Baihuanshu (BL30) and Huiyang (BL55) for chronic prostatitis. Method Ninety patients were divided into an acupuncture-medication group and a Chinese medication group, 45 in each group, to respectively receive electroacupuncture at Baihuanshu and Huiyang plus oral administration of Chinese medication, and single Chinese medication treatment, 4 weeks as a treatment course. The therapeutic efficacy was evaluated by adopting the Chronic Prostatitis Symptom Index by National Institutes of Health (NIH-CPSI). Result The general score of NIH-CPSI dropped in both groups after intervention (P<0.05), while the decrease in the acupuncture-medication group was more significant (P<0.05), and it had a significantly higher therapeutic efficacy than the Chinese medication group (P<0.05). Conclusion Electroacupuncture at Baihuanshu and Huiyang can significantly improve the symptoms of chronic prostatitis, and it’s superior to oral administration of Chinese medication in comparing the clinical efficacy.
2.Change of serum lipids and homocysteine levels in patients with ischemic cerebrovascular disease
Ronghua LI ; Siyou WEI ; Ji HAUNG ; Ping GUAN ; Zhou ZHU ; Daishi TIAN ; Huicong KANG
Journal of Clinical Medicine in Practice 2017;21(11):18-20
Objective To analyze the change of serum lipids and homocysteine level in patients with ischemic cerebrovascular disease.Methods A total of 150 patients with ischemic cerebrovascular disease (ICVD) were selected as ICVD group,and the patients were divided into short-term cerebral ischemia (TIA) group and cerebral infarction group (CI) group.Another 35 healthy people were selected as control group.Blood lipid index and plasma homocysteine level were compared among 4 groups.Results There was significant difference of Hcy between ICVD group,TIA group,CI group and control group (P<0.05).There was no significant difference of folic acid among the four groups (P>0.05).There were no significant differences in TC,TG and HDL-C between ICVD group,TIA group,CI group and control group (P>0.05),but there was significant difference in LDL-C (P<0.05).There were no significant differences in ApoA1 and ApoB between ICVD group,TIA group,CI group and control group (P>0.05),and there was significant difference in Fg (P<0.05).Conclusion Periodic detections of serum Hcy and blood lip index has a great value in prevention and treatment of patients with ischemic cerebrovascular disease.
3.Change of serum lipids and homocysteine levels in patients with ischemic cerebrovascular disease
Ronghua LI ; Siyou WEI ; Ji HAUNG ; Ping GUAN ; Zhou ZHU ; Daishi TIAN ; Huicong KANG
Journal of Clinical Medicine in Practice 2017;21(11):18-20
Objective To analyze the change of serum lipids and homocysteine level in patients with ischemic cerebrovascular disease.Methods A total of 150 patients with ischemic cerebrovascular disease (ICVD) were selected as ICVD group,and the patients were divided into short-term cerebral ischemia (TIA) group and cerebral infarction group (CI) group.Another 35 healthy people were selected as control group.Blood lipid index and plasma homocysteine level were compared among 4 groups.Results There was significant difference of Hcy between ICVD group,TIA group,CI group and control group (P<0.05).There was no significant difference of folic acid among the four groups (P>0.05).There were no significant differences in TC,TG and HDL-C between ICVD group,TIA group,CI group and control group (P>0.05),but there was significant difference in LDL-C (P<0.05).There were no significant differences in ApoA1 and ApoB between ICVD group,TIA group,CI group and control group (P>0.05),and there was significant difference in Fg (P<0.05).Conclusion Periodic detections of serum Hcy and blood lip index has a great value in prevention and treatment of patients with ischemic cerebrovascular disease.